Active, Not Recruiting
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
NCT03991832
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada